The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Nomura Raises Vodafone To Neutral From Reduce

Thu, 21st May 2015 08:42

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
NOMURA RAISES VODAFONE TO 'NEUTRAL' ('REDUCE') - PRICE TARGET 235 (185) PENCE
----------
CITIGROUP RAISES VODAFONE PRICE TARGET TO 265 (250) PENCE - 'BUY'
----------
JEFFERIES RAISES MARKS & SPENCER PRICE TARGET TO 665 (625) PENCE - 'BUY'
----------
HSBC RAISES MARKS & SPENCER PRICE TARGET TO 700 (630) PENCE - 'BUY'
----------
BARCLAYS RAISES MARKS & SPENCER TO EQUAL WEIGHT (UNDERWEIGHT)-TP 600 (390) PENCE
----------
SOCGEN RAISES MARKS & SPENCER PRICE TARGET TO 704 (640) PENCE - 'BUY'
----------
LIBERUM CUTS GKN TO 'HOLD' ('BUY') - TARGET 380 PENCE
----------
JEFFERIES RAISES GKN PRICE TARGET TO 415 (275) PENCE - 'BUY'
----------
JPMORGAN RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1100 (1050) PENCE - 'NEUTRAL'
----------
BERNSTEIN CUTS BURBERRY PRICE TARGET TO 1750 (1870) PENCE - 'MARKET-PERFORM'
----------
BERENBERG CUTS BURBERRY PRICE TARGET TO 1820 (1830) PENCE - 'HOLD'
----------
JEFFERIES CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1520) PENCE - 'HOLD'
----------
JEFFERIES CUTS ASTRAZENECA PRICE TARGET TO 5600 (5800) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES SAGE GROUP TO 'HOLD' ('SELL') - TARGET 590 (420) PENCE
----------
FTSE 250
----------
NUMIS RAISES AMLIN TO 'ADD' ('HOLD') - TARGET 535 PENCE
----------
Numis Upgrades Amlin To Add From Hold, Keeps Price Target At 535p
----------
MORGAN STANLEY RAISES PENNON GROUP TARGET TO 900 (890) PENCE - 'EQUAL-WEIGHT'
----------
EXANE BNP RAISES ZOOPLA PROPERTY TARGET TO 180 (170) PENCE - 'UNDERPERFORM'
----------
LIBERUM RAISES HOMESERVE PRICE TARGET TO 500 (450) PENCE - 'BUY' ------
----------
JPMORGAN RAISES HOMESERVE PRICE TARGET TO 407 (405) PENCE - 'NEUTRAL'
----------
Investec Lifts Booker Group Price Target To 185p From 178p, Keeps Buy
----------
Liberum Raises Shaftesbury Price Target To 905p From 871p, Reiterates Buy
----------
Investec Raises Halfords Group Price Target To 545p From 520p, Keeps Buy
----------
Berenberg Ups DS Smith Price Target To 350p From 340p, Keeps Hold
----------
GOLDMAN RAISES BIG YELLOW GROUP PT TO 954 (816) PENCE - 'CONVICTION BUY LIST'
----------
BERENBERG RAISES BIG YELLOW GROUP PRICE TARGET TO 700 (590) PENCE - 'HOLD'
----------
Liberum Downgrades ICAP To Sell From Hold, Price Target At 453p
----------
CITIGROUP RAISES VEDANTA PRICE TARGET TO 550 (430) PENCE - 'SELL'
----------
CITIGROUP RAISES DEBENHAMS PRICE TARGET TO 105 (95) PENCE - 'BUY'
----------
CITIGROUP CUTS AVEVA GROUP TO 'NEUTRAL' ('BUY') - TARGET 2025 (1745) PENCE
----------
JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 620 (585) PENCE - 'OVERWEIGHT'
----------
NOMURA RAISES ZOOPLA PROPERTY PRICE TARGET TO 285 (250) PENCE - 'BUY'
----------
GOLDMAN CUTS MELROSE PRICE TARGET TO 365 (370) PENCE - 'CONVICTION BUY LIST'
----------
CITIGROUP RAISES BRITVIC PRICE TARGET TO 880 (850) PENCE - 'BUY'
----------
SOCGEN CUTS BRITVIC PRICE TARGET TO 785 (805) PENCE - 'HOLD'
----------
TRADERS: HSBC INITIATES PETS AT HOME WITH 'BUY'
----------
MAIN MARKET AND AIM
----------
PANMURE RAISES YOUNG & COS BREWERY PRICE TARGET TO 1194 (1138) PENCE - 'BUY'
----------
PANMURE CUTS CRANEWARE TO 'HOLD' ('BUY') - TARGET 654 (609) PENCE
----------
JPMORGAN RAISES VECTURA GROUP PRICE TARGET TO 250 (230) PENCE - 'OVERWEIGHT'
----------
LIBERUM RAISES ASSURA GROUP PRICE TARGET TO 53 (50) PENCE - 'HOLD'
----------
JEFFERIES RAISES MARSHALLS GROUP PRICE TARGET TO 340 (330) PENCE - 'BUY'
----------
N+1 Singer Upgrades Low & Bonar To Buy From Hold, Price Target At 81p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.